ID   IBH-4
AC   CVCL_M356
DR   Wikidata; Q54897172
RX   PubMed=15095293;
RX   PubMed=19194992;
CC   Population: Caucasian.
CC   Characteristics: ER-alpha, ER-beta and PR-positive (PubMed=15095293).
CC   Doubling time: 43.47 hours (PubMed=15095293).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=15095293; DOI=10.1002/jcp.10466;
RA   Vazquez, Stella Maris
RA   Mladovan, Alejandro Gustavo
RA   Garbovesky, Carlos
RA   Baldi, Alberto
RA   Luthy, Isabel Alicia
RT   "Three novel hormone-responsive cell lines derived from primary human
RT   breast carcinomas: functional characterization.";
RL   J. Cell. Physiol. 199:460-469(2004).
//
RX   PubMed=19194992; DOI=10.1002/jcp.21694;
RA   Bruzzone, Ariana
RA   Vanzulli, Silvia Ines
RA   Soldati, Rocio
RA   Giulianelli, Sebastian
RA   Lanari, Claudia
RA   Luthy, Isabel Alicia
RT   "Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing
RT   in nude mice.";
RL   J. Cell. Physiol. 219:477-484(2009).
//